IVCC will participate at the International Conference on Vector-Borne Diseases (ICVB2025) jointly hosted by the Society for Vector Ecology (SOVE) Indian Region and the Academy of Public Health Entomology (APHE), India. The conference takes place at the Saveetha Institute of Medical and Technical Sciences in Chennai (SIMATS), India from the 21st to 24th January 2025.
IVCC CEO, Justin McBeath, will be giving a keynote address on the topic of ‘Perspectives on insecticide innovation for malaria vector control’. It takes place on Tuesday 21st January at 15:30*.
During the same session, Dr Vasantha Paul John, IVCC’s Registration Consultant, will give an invited talk on ‘Regulatory agility – The need for quick access of vector control tools’.
Other members of the IVCC team will also be in attendance and look forward to contributing insights and progress on expanding the vector control toolbox and the importance of combining tools to achieve malaria elimination.
Please visit the ICVB2025 event website for more information and the full programme.
*Times given in Indian Standard Time.
Commonwealth leaders and malaria community come together 24th May 2024On 25th May 2024, Malaria No More UK hosted a reception event alongside the Commonwealth Health Ministers Meeting in Geneva.
The reception brought together Commonwealth health ministers and senior officials, as well as the global malaria community to discuss and shine a light on what is needed to meet the commitments made on ending malaria.
The 2024 Commonwealth Malaria Report was also launched during the event. Produced by Malaria No More UK, African Leaders Malaria Alliance (ALMA) and Asia Pacific Leaders Malaria Alliance (APLMA), the report highlights efforts to end malaria across the Commonwealth. It includes case studies from five countries with a special focus on the Pacific region.
IVCC was proud to participate in the event to make the case for the importance of vector control and showcase our work in the Indo-Pacific, which has recently new grant funding from the Australian Government to support vector control innovation across the region.
IVCC at ICVB2025: Driving Innovation in Malaria Control and Vector Management in India 20th December 2024IVCC will participate at the International Conference on Vector-Borne Diseases (ICVB2025) jointly hosted by the Society for Vector Ecology (SOVE) Indian Region and the Academy of Public Health Entomology (APHE), India. The conference takes place at the Saveetha Institute of Medical and Technical Sciences in Chennai (SIMATS), India from the 21st to 24th January 2025.
IVCC CEO, Justin McBeath, will be giving a keynote address on the topic of ‘Perspectives on insecticide innovation for malaria vector control’. It takes place on Tuesday 21st January at 15:30*.
During the same session, Dr Vasantha Paul John, IVCC’s Registration Consultant, will give an invited talk on ‘Regulatory agility – The need for quick access of vector control tools’.
Other members of the IVCC team will also be in attendance and look forward to contributing insights and progress on expanding the vector control toolbox and the importance of combining tools to achieve malaria elimination.
Please visit the ICVB2025 event website for more information and the full programme.
*Times given in Indian Standard Time.
Zero malaria deaths are possible—but only if we harness the full power of innovation, partnership, and evidence-based action 29th January 2025Zero malaria deaths are possible—but only if we harness the full power of innovation, partnership, and evidence-based action.
IVCC CEO Justin McBeath, and IVCC Trustee Keziah Malm, in her role as Program Manager for Ghana’s National Malaria Elimination Program, join Medicines for Malaria Venture and PATH‘s Center for Vaccine Innovation and Access in this compelling opinion piece on achieving zero malaria deaths.
New insecticides are critical for combating resistance in mosquito populations and ensuring the continued effectiveness of widely used interventions such as insecticide-treated bed nets and indoor residual spraying. Vaccines RTS,S and R21 represent a breakthrough in reducing malaria morbidity and mortality, offering protection for children in areas with high and moderate transmission of Plasmodium falciparum, the deadliest form of the malaria parasite. Preventive interventions, such as seasonal malaria chemoprevention and intermittent preventive treatment in pregnancy, among others, protect the two populations most at risk: children and pregnant women.
While each of these tools has significant benefits on its own, their combined use creates a multilayered defense against malaria that is far more powerful than any single intervention. All three are needed to prevent malaria and reduce deaths in different populations and contexts.
Read their insights on how collaboration can transform global health, published in Devex, by following this link: https://ow.ly/KkZ350UBHzE
Sylando®: A new tool against vector-borne diseases 20th December 2024IVCC congratulates BASF on the news of the prequalification of Sylando® 240 SC by the World Health Organization (WHO). This is a welcome new mode of action in the indoor residual spraying (IRS) toolbox. Sylando® 240 SC represents a significant breakthrough, providing a new tool to allow programme managers to rotate between chemistries and be better equipped to manage resistance.
Similar to BASF’s Interceptor® G2 dual insecticide treated nets (ITNs), Sylando® 240 SC formulation contains chlorfenapyr; a potent insecticide for combating mosquitoes for public health.
IVCC supported BASF by providing scientific advice, laboratory support, and supporting rigorous field trials to prove Sylando® 240 SC’s efficacy.
Justin McBeath, Chief Executive Officer at IVCC, said: “Mosquito resistance to current insecticides has been one of the principal reasons for the recent stalling in the gains made since the turn of the century, so we desperately need effective chemistry with modes of action new to public health to combat these resistant mosquitoes, and enable rotation with other products. News that Sylando® 240 SC has recently obtained a WHO PQ listing is therefore very welcome and will prove to be a very valuable part of the vector control toolbox.”
The new BASF Public Health product will be available to protect people from vector-borne diseases such as malaria.
For further information on the WHO Prequalification of Sylando® 240 SC visit: https://extranet.who.int/prequal/vector-control-products/sylando-240-sc